In their IHC-based study, Lindgren et al. analyzed 53 benign, borderline, and malignant ovarian tumors of different types and found a significantly lower ERβ expression in ovarian cancer tissue compared to normal ovaries [54]. The gene discussed is ESR2; the disease is ovarian cancer.